Investigation of Heart Failure Status Over Time Using Respiratory Parameters
Completed
- Conditions
- Heart Failure, CongestiveSleep Apnea Syndromes
- Registration Number
- NCT00494117
- Lead Sponsor
- ResMed
- Brief Summary
The purpose of the study is to investigate respiratory indicators for clinically important changes in Heart Failure status over time.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Moderate to severe Heart Failure (as determined by Echocardiogram or by treating physician)
Exclusion Criteria
- Malignant disease affecting gas exchange or respiratory parameters
- Medications compromising breathing with no adverse affects on heart failure
- Clinically significant (moderate to severe) asthma requiring therapy
- Chronic parenchymal lung disease (FEV1/FVC ratio = 65% or as determined by the treating physician)
- Severe pulmonary hypertension
- Heart failure due to alcohol abuse or chemotherapy
- Narcotic abuse/intravenous drug use (including HIV+ and hepatitis C)
- Alcohol consumption > 80g/day
- Patients receiving home Oxygen
- Methicillin- resistant Staphylococcus aureus infection
- Narcolepsy
- Cataplexy
- Enrolled in any concurrent study, that may confound the results of this study.
- Inability or refusal to sign the Patient Consent Form
- Inability or refusal to adhere to protocol requirements
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Royal Prince Alfred Hospital
🇦🇺Camperdown, New South Wales, Australia